![]() | |
Company type | Public limited company |
---|---|
Industry | Pharmaceutical |
Founded | 1993 |
Defunct | 1999 |
Fate | Merged with Astra AB |
Successor | AstraZeneca |
Headquarters | London, UK |
Products | Pharmaceutical products |
Zeneca (officially Zeneca Group PLC) was a British multinational pharmaceutical company headquartered in London, United Kingdom. It was formed in June 1993 by the demerger of the pharmaceuticals and agrochemicals businesses of Imperial Chemical Industries into a separate company listed on the London Stock Exchange.[1]
In 1999, Zeneca and the Sweden-based pharmaceutical company Astra AB merged to form AstraZeneca plc.[2][3]
Zeneca's largest therapeutic area was oncology, in which its key products included Casodex, Nolvadex and Zoladex.[4] Other key products included heart drug Tenormin.[5]